Prognostic value of circulating cytokines for stage III colon cancer

Journal of Surgical Research

Volumn 182, Issue 1, 2013, Pages 49-54

  Lee, Won Suk ^a   Baek, Jeong Heum ^a   You, Dong Hun ^a   Nam, Myeong Jin ^a  

^a Gachon University College of Medicine   (South Korea)

Author keywords

Colon neoplasm; CRP; EGFR; IL 6

Indexed keywords

C REACTIVE PROTEIN; EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; INTERLEUKIN 6; OXALIPLATIN;

ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; COLON ADENOCARCINOMA; DISEASE FREE SURVIVAL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; LYMPH VESSEL METASTASIS; MAJOR CLINICAL STUDY; MALE; PREOPERATIVE PERIOD; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION;

ADENOCARCINOMA; ADULT; AGED; C-REACTIVE PROTEIN; COLONIC NEOPLASMS; CYTOKINES; DISEASE-FREE SURVIVAL; EPIDERMAL GROWTH FACTOR; FEMALE; FOLLOW-UP STUDIES; HUMANS; INTERLEUKIN-6; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; RETROSPECTIVE STUDIES; TUMOR MARKERS, BIOLOGICAL;

EID: 84876695534     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1016/j.jss.2012.08.051     Document Type: Article

References (36)

1. A.M. Jemal Cancer statistics Cancer J Clin 53 2003 5
2. W.S. Lee, J.H. Baek, J.N. Lee, and W.K. Lee Mutations in K-ras and epidermal growth factor receptor expression in Korean patients with stages III and IV colorectal cancer Int J Surg Pathol 19 2011 145
3. Y.J. Won, J. Sung, and K.W. Jung Nationwide cancer incidence in Korea, 2003-2005 Cancer Res Treat 41 2009 122
4. J.R. Jass, S.B. Love, and J.M. Northover A new prognostic classification of rectal cancer Lancet 1 1987 1303
5. J.A. Laurie, C.G. Moertel, and T.R. Fleming Surgical adjuvant therapy of large-bowel carcinoma: an evaluation of levamisole and the combination of levamisole and fluorouracil. The North Central Cancer Treatment Group and the Mayo Clinic J Clin Oncol 7 1989 1447
6. B.G. Taal, H. Van Tinteren, and F.A. Zoetmulder Adjuvant 5FU plus levamisole in colonic or rectal cancer: improved survival in stage II and III Br J Cancer 85 2001 1437
7. N. Wolmark, L. Colangelo, and S. Wieand National Surgical Adjuvant Breast and Bowel Project trials in colon cancer Semin Oncol 28 2001 9
8. C.G. Moertel, T.R. Fleming, and J.S. Macdonald Fluorouracil plus levamisole as effective adjuvant therapy after resection of stage III colon carcinoma: a final report Ann Intern Med 122 1995 321
9. D.J. Ahnen, P. Feigl, and G. Quan Ki-ras mutation and p53 overexpression predict the clinical behavior of colorectal cancer: a Southwest Oncology Group study Cancer Res 58 1998 1149
10. H.J. Andreyev, A.R. Norman, and D. Cunningham Kirsten ras mutations in patients with colorectal cancer: the 'RASCAL II' study Br J Cancer 85 2001 692
11. K.C. Halling, A.J. French, and S.K. McDonnell Microsatellite instability and 8p allelic imbalance in stage B2 and C colorectal cancers J Natl Cancer Inst 91 1999 1295
12. U. McDermott, D.B. Longley, and P.G. Johnston Molecular and biochemical markers in colorectal cancer Ann Oncol 13 Suppl 4 2002 235
13. J.Y. Wang, C.Y. Lu, and K.S. Chu Prognostic significance of pre- and postoperative serum carcinoembryonic antigen levels in patients with colorectal cancer Eur Surg Res 39 2007 245
14. W.S. Lee, J.H. Baek, K.K. Kim, and Y.H. Park The prognostic significant of percentage drop in serum CEA post curative resection for colon cancer Surg Oncol 21 2012 45
15. D.J. Deehan, S.D. Heys, W.G. Simpson, J. Broom, C. Franks, and O. Eremin In vivo cytokine production and recombinant interleukin 2 immunotherapy: an insight into the possible mechanisms underlying clinical responses Br J Cancer 69 1994 1130
16. C. Belluco, D. Nitti, and M. Frantz Interleukin-6 blood level is associated with circulating carcinoembryonic antigen and prognosis in patients with colorectal cancer Ann Surg Oncol 7 2000 133
17. T. Cohen, D. Nahari, L.W. Cerem, G. Neufeld, and B.Z. Levi Interleukin 6 induces the expression of vascular endothelial growth factor J Biol Chem 271 1996 736
18. N.I. Nikiteas, N. Tzanakis, and M. Gazouli Serum IL-6, TNFalpha and CRP levels in Greek colorectal cancer patients: prognostic implications World J Gastroenterol 11 2005 1639
19. P.B. Sehgal Regulation of IL6 gene expression Res Immunol 143 1992 724
20. B.L. Pierce, R. Ballard-Barbash, and L. Bernstein Elevated biomarkers of inflammation are associated with reduced survival among breast cancer patients J Clin Oncol 27 2009 3437
21. S.M. Zhang, J. Lin, and N.R. Cook C-reactive protein and risk of breast cancer J Natl Cancer Inst 99 2007 890
22. T.P. Erlinger, E.A. Platz, N. Rifai, and K.J. Helzlsouer C-reactive protein and the risk of incident colorectal cancer JAMA 291 2004 585
23. M.J. Gunter, R. Stolzenberg-Solomon, and A.J. Cross A prospective study of serum C-reactive protein and colorectal cancer risk in men Cancer Res 66 2006 2483
24. D. Il'yasova, L.H. Colbert, and T.B. Harris Circulating levels of inflammatory markers and cancer risk in the health aging and body composition cohort Cancer Epidemiol Biomarkers Prev 14 2005 2413
25. J. Baselga, and C.L. Arteaga Critical update and emerging trends in epidermal growth factor receptor targeting in cancer J Clin Oncol 23 2005 2445
26. A.R. Li, D. Chitale, and G.J. Riely EGFR mutations in lung adenocarcinomas: clinical testing experience and relationship to EGFR gene copy number and immunohistochemical expression J Mol Diagn 10 2008 242
27. L.M. Sholl, Y. Xiao, and V. Joshi EGFR mutation is a better predictor of response to tyrosine kinase inhibitors in non-small cell lung carcinoma than FISH, CISH, and immunohistochemistry Am J Clin Pathol 133 2010 922
28. T. Andre, C. Boni, and L. Mounedji-Boudiaf Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer N Engl J Med 350 2004 2343
29. H. Komoda, Y. Tanaka, M. Honda, Y. Matsuo, K. Hazama, and T. Takao Interleukin-6 levels in colorectal cancer tissues World J Surg 22 1998 895
30. G. Galizia, M. Orditura, and C. Romano Prognostic significance of circulating IL-10 and IL-6 serum levels in colon cancer patients undergoing surgery Clin Immunol 102 2002 169
31. J. Van Snick Interleukin-6: an overview Annu Rev Immunol 8 1990 253
32. D.K. Biswas, and J.D. Iglehart Linkage between EGFR family receptors and nuclear factor kappaB (NF-kappaB) signaling in breast cancer J Cell Physiol 209 2006 645
33. D. Nichols, J. Chmiel, and M. Berger Chronic inflammation in the cystic fibrosis lung: alterations in inter- and intracellular signaling Clin Rev Allergy Immunol 34 2008 146
34. I. Tamm, I. Cardinale, and P.B. Sehgal Interleukin-6 and 12-O-tetradecanoyl phorbol-13-acetate act synergistically in inducing cell-cell separation and migration of human breast carcinoma cells Cytokine 3 1991 212
35. T. Ashizawa, R. Okada, and Y. Suzuki Clinical significance of interleukin-6 (IL-6) in the spread of gastric cancer: role of IL-6 as a prognostic factor Gastric Cancer 8 2005 124
36. T. Nozoe, T. Matsumata, and K. Sugimachi Preoperative elevation of serum C-reactive protein is related to impaired immunity in patients with colorectal cancer Am J Clin Oncol 23 2000 263